The expanding role of primary care in cancer control
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10321557" target="_blank" >RIV/00216208:11110/15:10321557 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1016/S1470-2045(15)00205-3" target="_blank" >http://dx.doi.org/10.1016/S1470-2045(15)00205-3</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/S1470-2045(15)00205-3" target="_blank" >10.1016/S1470-2045(15)00205-3</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The expanding role of primary care in cancer control
Popis výsledku v původním jazyce
The nature of cancer control is changing, with an increasing emphasis, fuelled by public and political demand, on prevention, early diagnosis, and patient experience during and after treatment. At the same time, primary care is increasingly promoted, bygovernments and health funders worldwide, as the preferred setting for most health care for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference for care close to home. It is timely, then, to consider how thisexpanding role for primary care can work for cancer control, which has long been dominated by highly technical interventions centred on treatment, and in which the contribution of primary care has been largely perceived as marginal. In this Commission,expert opinion from primary care and public health professionals with academic and clinical cancer expertise-from epidemiologists, psychologists, policy makers, and cancer specialists-has contributed to a detailed consideration of the evi
Název v anglickém jazyce
The expanding role of primary care in cancer control
Popis výsledku anglicky
The nature of cancer control is changing, with an increasing emphasis, fuelled by public and political demand, on prevention, early diagnosis, and patient experience during and after treatment. At the same time, primary care is increasingly promoted, bygovernments and health funders worldwide, as the preferred setting for most health care for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference for care close to home. It is timely, then, to consider how thisexpanding role for primary care can work for cancer control, which has long been dominated by highly technical interventions centred on treatment, and in which the contribution of primary care has been largely perceived as marginal. In this Commission,expert opinion from primary care and public health professionals with academic and clinical cancer expertise-from epidemiologists, psychologists, policy makers, and cancer specialists-has contributed to a detailed consideration of the evi
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2015
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Lancet Oncology
ISSN
1470-2045
e-ISSN
—
Svazek periodika
16
Číslo periodika v rámci svazku
12
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
42
Strana od-do
1231-1272
Kód UT WoS článku
000361876000006
EID výsledku v databázi Scopus
2-s2.0-84942576701